The Cigna Group (NYSE:CI) Shares Bought by Royal Fund Management LLC

Royal Fund Management LLC boosted its stake in shares of The Cigna Group (NYSE:CIFree Report) by 5.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,232 shares of the health services provider’s stock after acquiring an additional 223 shares during the quarter. Royal Fund Management LLC’s holdings in The Cigna Group were worth $1,270,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in CI. Bogart Wealth LLC lifted its holdings in shares of The Cigna Group by 104.5% in the 3rd quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 46 shares during the period. OFI Invest Asset Management acquired a new stake in shares of The Cigna Group in the 3rd quarter valued at approximately $26,000. Fortitude Family Office LLC acquired a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $29,000. VisionPoint Advisory Group LLC lifted its holdings in shares of The Cigna Group by 112.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock valued at $30,000 after buying an additional 55 shares during the period. Finally, Pacifica Partners Inc. lifted its holdings in shares of The Cigna Group by 73.2% in the 4th quarter. Pacifica Partners Inc. now owns 142 shares of the health services provider’s stock valued at $43,000 after buying an additional 60 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at The Cigna Group

In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total value of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares in the company, valued at $694,668.96. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the sale, the senior vice president now directly owns 2,102 shares of the company’s stock, valued at $694,668.96. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO David Cordani sold 31,209 shares of the company’s stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $355.17, for a total value of $11,084,500.53. Following the transaction, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at $123,618,339.18. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 114,144 shares of company stock valued at $39,296,330. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Wells Fargo & Company lifted their price objective on The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Deutsche Bank Aktiengesellschaft raised The Cigna Group from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $355.00 to $370.00 in a report on Thursday, February 1st. Oppenheimer lifted their price objective on The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Friday. Royal Bank of Canada raised The Cigna Group from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $327.00 to $354.00 in a report on Monday, February 5th. Finally, Mizuho lifted their price objective on The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $366.14.

View Our Latest Research Report on CI

The Cigna Group Trading Down 0.9 %

Shares of NYSE:CI traded down $3.00 during midday trading on Friday, reaching $341.50. The company’s stock had a trading volume of 2,413,548 shares, compared to its average volume of 1,380,653. The firm has a market cap of $99.84 billion, a price-to-earnings ratio of 28.04, a price-to-earnings-growth ratio of 1.05 and a beta of 0.57. The company has a quick ratio of 0.67, a current ratio of 0.71 and a debt-to-equity ratio of 0.75. The Cigna Group has a 1 year low of $240.50 and a 1 year high of $365.71. The business has a 50 day moving average price of $350.77 and a 200 day moving average price of $319.59.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, beating analysts’ consensus estimates of $6.17 by $0.30. The business had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.41 earnings per share. Research analysts forecast that The Cigna Group will post 28.4 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be given a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date is Tuesday, June 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 45.98%.

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.